Literature DB >> 7425377

Neostigmine, pyridostigmine, and edrophonium as antagonists of pancuronium.

A Ferguson, P Egerszegi, D R Bevan.   

Abstract

This study was performed to compare the effects of three anticholinesterases on rates of recovery from pancuronium-induced neuromuscular blockade. Pancuronium (3 mg/70 kg) was antagonized during nitrous oxide-oxygen-halothane anesthesia, in man, with neostigmine (2.5 or 5.0 mg/70 kg), pyridostigmine (10 or 20 mg/70 kg), or edrophonium (50 or 100 mg/70 kg). Reversal was attempted at 10 per cent spontaneous recovery of muscle twitch, which was measured by use of train-of-four stimulation. Following administration of the antagonists each patient had progressive recovery of neuromuscular function. Recurarization was not observed during the period of study. Recovery was most rapid with edrophonium and slowest with pyridostigmine. Five minutes after administration of the antagonists, mean T4, the height of the fourth twitch as a percentage of the first in each train, exceeded 50 per cent only with the larger dose of neostigmine and both doses of edrophonium. Thirty minutes after reversal there was no significant difference in recoveries among the drugs tested, and T4 exceeded 70 per cent for all patients. It is concluded that, under the conditions of this study, neostigmine, pyridostigmine, and edrophonium induce sustained antagonism of pancuronium-induced neuromuscular blockade. The antagonism produced by large doses of edrophonium is faster than that produced by neostigmine or pyridostigmine.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7425377     DOI: 10.1097/00000542-198011000-00006

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  10 in total

1.  The current status of edrophonium: have we come "full circle"?

Authors:  A F Kopman
Journal:  Can J Anaesth       Date:  1991-03       Impact factor: 5.063

Review 2.  A simulation of neuromuscular function and heart rate during induction, maintenance, and reversal of neuromuscular blockade.

Authors:  R R Jaklitsch; D R Westenskow
Journal:  J Clin Monit       Date:  1990-01

Review 3.  Neuromuscular blocking drugs in anaesthesia.

Authors:  F Donati; J C Bevan; D R Bevan
Journal:  Can Anaesth Soc J       Date:  1984-05

Review 4.  Neuromuscular blocking drugs.

Authors:  D R Bevan
Journal:  Can Anaesth Soc J       Date:  1983-05

5.  Neostigmine, pyridostigmine and edrophonium as antagonists of deep pancuronium blockade.

Authors:  F Donati; J Lahoud; D McCready; D R Bevan
Journal:  Can J Anaesth       Date:  1987-11       Impact factor: 5.063

Review 6.  New intravenous anaesthetics and neuromuscular blocking drugs. A review of their properties and clinical use.

Authors:  C S Reilly; W S Nimmo
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

7.  Neostigmine and edrophonium for reversal of pipecuronium neuromuscular blockade.

Authors:  M Abdulatif; M Naguib
Journal:  Can J Anaesth       Date:  1991-03       Impact factor: 5.063

8.  ORG NC45 for short intra-abdominal operations: a comparison with succinylcholine.

Authors:  H Gyasi; A Williams; C Melloni; D R Beran
Journal:  Can Anaesth Soc J       Date:  1983-03

9.  Edrophonium requirements for reversal of deep neuromuscular block following infusion of mivacurium.

Authors:  D R Miller; G Bryson; R J Martineau; J B Kitts; M Curran; P Bragg; J B Watson; K Hull; P Lindsay
Journal:  Can J Anaesth       Date:  1995-11       Impact factor: 5.063

10.  Effect of halogenated anaesthetics on heart rate changes during reversal of neuromuscular block with glycopyrrolate and neostigmine.

Authors:  S K Samra; U Pandit; S K Pandit; S P Kothary
Journal:  Can Anaesth Soc J       Date:  1984-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.